Leaderboard

En | De
Sie sind hier: Gastroenterologie » Oesophagus » Neoplasie 14. März 2026
Suchen
medline.ch
Neoplasie
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gallenwege
Leber
Magen-Darm
Oesophagus
Motilitätsstörungen
Neoplasie
Anderes
Pankreas
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 1923  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 38451  
   
Advanced imaging (narrow band and acetic acid chromoendoscopy) and guided biopsies in surveillance of Barrett's oesophagus: a systematic review.
BMJ Open Gastroenterol
Gamakaranage C, Butler TD, Ratcliffe E, Britton J, Keld R, Prasad N, Hamdy S, McLaughlin J, Ang Y.
PMID: 41825912 [PubMed - indexed for MEDLINE]


Dietary fat consumption and cancer outcomes: An umbrella review of systematic reviews and meta-analyses.
Am J Clin Nutr
Fan B, Zhang Z, Zhang Y, Guo Q, Chen P, Jian L, Pang L, Wu Y, Wang S.
PMID: 41825531 [PubMed - as supplied by publisher]


CT imaging is a feasible method for the preoperative prediction of the main pathologic response after neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma.
Updates Surg
Zhou H, Wei WW, Lin JP, Gao PQ, He H, Liu SY, Wang F.
PMID: 41824274 [PubMed - as supplied by publisher]


Real-world experience with first-line pembrolizumab plus chemotherapy in Vietnamese patients with stage IV esophageal squamous cell carcinoma.
Front Immunol
Van Tran T, Nguyen PT, Van Le Q, Nguyen GHT, Le Trinh H, Le KH, Hoang GN.
PMID: 41822478 [PubMed - indexed for MEDLINE]


Clinical Implications of Nutritional Intake in Patients With Esophageal Squamous Cell Carcinoma Receiving Chemoradiotherapy and Neoadjuvant Chemotherapy.
Cancer Med
Tamai Y, Yamada A, Katada C, Tamaoki M, Nomura M, Yokoyama A, Inoo H, Fujii K, Sakanaka K, Tsunoda S, Ohashi S, Nishikawa Y, Inoue M, Obama K, Mizowaki T, Muto M.
PMID: 41821148 [PubMed - indexed for MEDLINE]


Adebrelimab plus chemotherapy as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma (ESCC): a single-center, phase II, single-arm, open-label clinical trial (ADENEO) protocol.
BMC Cancer
Tang P, Gao L, Zuo S, Zhang K, Wang T, Zheng J, Chen X, Dong J, Pang Q, Wang P, Zhang W, Zhang T.
PMID: 41820935 [PubMed - as supplied by publisher]


Cross-cancer survival prediction using machine learning models.
Sci Rep
Cardoso LB, Egydio JE, Toporcov TN, Utida NY, Curado MP, Fernandes GA, Ribeiro AG, Chin BG, Parro VC.
PMID: 41820406 [PubMed - as supplied by publisher]


Camrelizumab plus CAPOX with camrelizumab based maintenance versus CAPOX alone as initial treatment for gastric or gastro-oesophageal junction adenocarcinoma: randomised phase 3 trial.
BMJ
Peng Z, Zhang Y, Xu H, Yang Y, Yang M, Zhang M, Cheng Y, Chen X, Pan Y, Wang F, Li Q, Xu N, Liu L, Gu K, Xiao J, Zhang R, Zhao Q, Chen J, Lin L, Chen Y, Deng Y, Cai S, Bai B, Wang Y, Shen L.
PMID: 41819560 [PubMed - indexed for MEDLINE]


Preoperative expiratory muscle training for swallowing function in patients with esophageal cancer undergoing esophagectomy: A randomized controlled phase II trial protocol.
PLoS One
Mizusawa H, Noguchi M, Tamura T, Shiraishi M, Kanki K, Shiraishi O, Hiraki Y, Kato H, Higashimoto Y, Yasuda T.
PMID: 41818249 [PubMed - indexed for MEDLINE]


Identification and validation of an explainable machine learning model for early postoperative pulmonary complications after esophagectomy in patients with esophageal cancer.
J Gastrointest Oncol
Liu F, Wang Z.
PMID: 41816575 [PubMed]


Integration of CT radiomics and machine learning for preoperative T staging of esophageal squamous cell carcinoma.
J Thorac Dis
Zhang X, Chen J, Wu W, Liu L, He P, Wu Y.
PMID: 41816436 [PubMed]


Gustave Roussy Immune Score as a prognostic marker in patients with esophageal cancer after neoadjuvant chemoradiotherapy: a retrospective study.
J Thorac Dis
Zhang L, Liang Z, Fang P, Zhou J, Yang Y, Luan S, Xiao X, Li X, Gu Y, Zhang H, Chen L, Zeng X, Yuan Y.
PMID: 41816398 [PubMed]


Fear of cancer recurrence in patients undergoing active surveillance versus standard surgery for oesophageal cancer (SANO-trial).
Br J Surg
Gangaram Panday SSG, SANO Study Group.
PMID: 41814844 [PubMed - as supplied by publisher]


Research progress on the compositional characteristics of the tumor immune microenvironment and immunopredictive models in esophageal squamous cell carcinoma.
Cancer Biol Ther
Wang G, Li Z, Tan S, Ma J, Yin Z, Du J, Fan L.
PMID: 41814475 [PubMed - indexed for MEDLINE]


Length of stay affects long-term survival after esophageal cancer surgery: retrospective cohort study.
J Cardiothorac Surg
Dai YY, Yuan YP, Zheng YL, Wang FX.
PMID: 41814340 [PubMed - as supplied by publisher]


Lessons learned: the importance of timely recognition of verrucous squamous cell carcinoma in the esophagus.
Dis Esophagus
Provoost N, Zellenrath PA, Plompen EPC, Oudijk L, Koehler EM, Utomo W, van Tilburg AJP, Anten MP, Hazen WL, Akta, Koch AD, Honing J, Spaander MCW.
PMID: 41812246 [PubMed - indexed for MEDLINE]


Dosimetric comparison study of ultrahypofractionated photon versus proton treatment plans in post breast-conserving surgery breast cancer.
PLoS One
Saksornchai K, Tawonwong T, Oonsiri P, Vimolnoch M, Sarsitthithum T, Lertbutsayanukul C, Nantavithya C.
PMID: 41811865 [PubMed - indexed for MEDLINE]


Predictors of Post-Definitive Chemoradiotherapy Esophageal Stricture in T2-T4 Esophageal Squamous Cell Carcinoma: : A Single-Center Retrospective Study.
J Gastrointest Cancer
Ishida R, Nagata K, Horitani S, Futai R, Tokuyama N, Tobimatsu K, Kodama Y.
PMID: 41811572 [PubMed - indexed for MEDLINE]


Multicentre dosimetry audit in the European randomized phase III study of neoadjuvant chemoradiotherapy using proton versus photon radiotherapy in locally advanced oesophageal cancer.
Phys Imaging Radiat Oncol
Ehmsen ML, Byskov CS, Mortensen HR, Bütof R, Canters R, Defraene G, Haustermans K, Jensen MF, Meijers A, Muijs CT, Møller DS, Nordsmark M, Populaire P, Vilches-Freixas G, Nyvang L, Stolarczyk L, Makocki S, Broggi S, Fracchiolla F, Martignano A, Poels K, Rossomme S, Vasiliniuc S, Hoffmann L.
PMID: 41810037 [PubMed]


High PD-L1 expression as a negative prognostic factor in stage III but not in stage II gastric cancer.
World J Gastroenterol
Zhang HM, Li FP, Zhang HY, Liu XR, Chen XH, Liang HY, Yan X, Xie Q, Zhong R, Lai M, Zhong XF, Liu H, Zhao LY.
PMID: 41809879 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 38451    Seite 1 von 1923  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1